Table 4.
Logistic regression analysis of the significant risk factors in association with CLNM
| Factors | β | S.E. | P value | OR value | 95% CI |
|---|---|---|---|---|---|
|
Final pathological factors |
|
|
|
|
|
| Gender (M/F) |
1.578 |
0.592 |
0.008 a |
4.848 |
1.519–15.466 |
| Age (<50y/≥50y) |
1.236 |
0.428 |
0.004a |
3.442 |
1.488–7.963 |
| Tumor size (≥7 mm/<7 mm) |
1.067 |
0.419 |
0.011a |
2.908 |
1.278–6.614 |
| Multifocality |
0.991 |
0.667 |
0.138 |
2.693 |
0.728–9.956 |
| Bilateral PTMC |
0.436 |
0.484 |
0.367 |
1.547 |
0.600–3.993 |
| Constant |
−1.787 |
0.448 |
|
|
|
|
Preoperative factors |
|
|
|
|
|
| Gender (M/F) |
1.591 |
0.596 |
0.008a |
4.910 |
1.526–15.796 |
| Age (<50y/≥50y) |
1.199 |
0.424 |
0.005a |
3.311 |
1.443–7.634 |
| Preoperative tumor size (≥ 7 mm/<7 mm) |
1.086 |
0.418 |
0.009a |
2.964 |
1.305–6.729 |
| Preoperative multifocality |
0.806 |
0.706 |
0.253 |
2.240 |
0.562–8.931 |
| Bilateral PTMC |
0.584 |
0.466 |
0.210 |
1.793 |
0.719–4.469 |
| Constant | −0.600 | 0.371 |
aStatistically significant (P < 0.05).